Drugs / JNJ-18054478
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00530166 | Jul 2007 → Jul 2008 | asthma | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Terminated | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | JNJ-18054478 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00530166 ↗ |
| Route | Oral | “JNJ-18054478 orally once daily” NCT00530166 ↗ |